Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

microcuff GMBH

This article was originally published in Start Up

Executive Summary

microcuff GMBH, a German manufacturer of an innovative cuff material and design has found its first application in intensive care ventilation.

You may also be interested in...



The Lonely World of European Device Start-Ups

Because of a conservative clinical culture and a skittish venture community, medical-device company creation has lagged in Europe. The reasons for the lack of device company creation are several: a physician community that is not only not entrepreneurial, but often averse to capitalizing on commercial opportunities; a venture capital community unfamiliar with devices; and a lack of

Medical Device Start-Ups in Germany

Despite the important role that French, German, and other European physicians play in developing and trialing new technology, and the equally important role that EU regulators play in offering a quick path to commercialization, the number of native European medical device companies is surprisingly small. There are hints that the bleak devicie picture might be brightening, however.

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel